467 related articles for article (PubMed ID: 8543838)
1. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
2. Humoral autoimmune responses to glutamic acid decarboxylase have similar target epitopes and subclass that show titer-dependent disease association.
Piquer S; Belloni C; Lampasona V; Bazzigaluppi E; Vianello M; Giometto B; Bosi E; Bottazzo GF; Bonifacio E
Clin Immunol; 2005 Oct; 117(1):31-5. PubMed ID: 16027042
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
[TBL] [Abstract][Full Text] [Related]
4. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome.
Butler MH; Solimena M; Dirkx R; Hayday A; De Camilli P
J Exp Med; 1993 Dec; 178(6):2097-106. PubMed ID: 8245784
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
7. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
8. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
Björk E; Velloso LA; Kämpe O; Karlsson FA
Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
[TBL] [Abstract][Full Text] [Related]
9. Two distinct glutamic acid decarboxylase auto-antibody specificities in IDDM target different epitopes.
Daw K; Powers AC
Diabetes; 1995 Feb; 44(2):216-20. PubMed ID: 7532143
[TBL] [Abstract][Full Text] [Related]
10. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
11. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies.
Bonifacio E; Lampasona V; Genovese S; Ferrari M; Bosi E
J Immunol; 1995 Dec; 155(11):5419-26. PubMed ID: 7594559
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of epitope recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different autoimmune disorders.
Powers AC; Bavik K; Tremble J; Daw K; Scherbaum WA; Banga JP
Clin Exp Immunol; 1999 Dec; 118(3):349-56. PubMed ID: 10594551
[TBL] [Abstract][Full Text] [Related]
14. Distinct antigenic features of linear epitopes at the N-terminus and C-terminus of 65 kDa glutamic acid decarboxylase (GAD65): implications for autoantigen modification during pathogenesis.
Al-Bukhari TA; Radford PM; Bouras G; Davenport C; Trigwell SM; Bottazzo GF; Lai M; Schwartz HL; Tighe PJ; Todd I
Clin Exp Immunol; 2002 Oct; 130(1):131-9. PubMed ID: 12296864
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
16. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
[TBL] [Abstract][Full Text] [Related]
18. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
Khan MW; Sherwani S; Khan WA; Ali R
Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
[TBL] [Abstract][Full Text] [Related]
20. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
Bonifacio E; Lampasona V; Bingley PJ
J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
